Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PROBES: Safety of micronized progesterone vs norethisterone acetate with oral estrogen in menopausal hormone therapy
2021-001624-17Phase 3Active
- Sponsor
- Karolinska University Hospital
- Start
- Jun 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in menopause comparing Micronized progesterone + estradiol with Norethisterone acetate + estradiol (2 arms). Primary endpoint: Percentage change in mammographic density. Started Jun 2021; status: active.
02
Drugs
progesteronenorethisterone acetateestradiol
03
Conditions
menopause
Beyond the preview
Go deeper on 2021-001624-17.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2021-001624-17.